Predict your next investment

HEALTHCARE | Drug Development
entomopharm.se

See what CB Insights has to offer

Stage

Seed | Dead

Total Raised

$1.04M

Last Raised

$1.04M

About Entomopharm

Provider of insect based screening models for predicting absorption, distribution, metabolic, or excretion (ADME) properties of chemical agents. The company provides insect models to be used for the drug discovery process. Insect models can be used in early drug discovery phase, to tackle ADME problems and understand the disposition of a pharmaceutical compound within an organism. The two in vivo and ex vivo models are based on the locust migratory to determine the blood-brain barrier (BBB) permeability.

Entomopharm Headquarter Location

Fruebjergvej 3

Copenhagen, 2100,

Denmark

45 39 17 98 55

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Entomopharm Patents

Entomopharm has filed 5 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/16/2009

11/24/2015

Peripherally selective drugs, Drug discovery, Analgesics, Radiobiology, Piperidines

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

9/16/2009

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

11/24/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Peripherally selective drugs, Drug discovery, Analgesics, Radiobiology, Piperidines

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.